Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:14:45 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



News for U:XRTX from 2023-05-02 to 2024-05-01 - 36 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-30 13:55U:XRTXNews ReleaseXORTX Reprices Warrants Issued in Connection with Previous Private Placements
2024-04-22 07:00U:XRTXNews ReleaseXORTX Announces Publication of Key Research in ADPKD
2024-04-21 19:02U:XRTXNews ReleaseMoney Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NASDAQ:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future
2024-04-08 07:30U:XRTXNews ReleaseXORTX Welcomes New Member to the Board of Directors
2024-04-08 07:00U:XRTXNews ReleaseXORTX Announces Participation in Spring 2024 Investor Conferences
2024-03-27 05:00U:XRTXNews ReleaseXORTX Announces New Clinical Advisory Board Member
2024-03-19 09:32U:XRTXNews ReleaseXORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
2024-03-19 05:00U:XRTXNews ReleaseXORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
2024-03-11 07:00U:XRTXNews ReleaseXORTX Reprices Warrants Issued in Connection with Previous Private Placements
2024-03-04 07:00U:XRTXNews ReleaseXORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units
2024-03-03 06:34U:XRTXNews ReleaseMONEY TALK RADIO with XORTX Therapeutics Inc. (XRTX) Dr. Allen Davidoff Explains Advanced Drug Therapy for Kidney Disease and Diabetes
2024-02-15 07:00U:XRTXNews ReleaseXORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units
2024-02-01 20:46U:XRTXNews ReleaseXORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units
2024-01-15 07:00U:XRTXNews ReleaseXORTX Announces $2 Million Public Offering
2024-01-03 07:00U:XRTXNews ReleaseXORTX Submits a New Patent ‚  for the Treatment of Chronic Kidney Disease
2024-01-02 07:00U:XRTXNews ReleaseXORTX Welcomes New Member to the Board of Directors
2023-11-30 07:30U:XRTXNews ReleaseXORTX Announces US ATM Offering
2023-11-29 07:00U:XRTXNews ReleaseXORTX Meets Nasdaq Continued Listing Requirements
2023-11-10 07:00U:XRTXNews ReleaseXORTX Clarifies Timing for Share Consolidation
2023-11-08 17:00U:XRTXNews ReleaseXORTX Announces Share Consolidation
2023-11-02 07:00U:XRTXNews ReleaseXORTX Sponsored Study Presented at the American Society of Nephrology ¢ € “ Kidney Week 2023
2023-10-27 17:30U:XRTXNews ReleaseXORTX Announces Results of Special Meeting of Shareholders
2023-10-25 17:00U:XRTXNews ReleaseXORTX Announces Date for Rescheduled ‚  Special Meeting of Shareholders
2023-10-25 07:00U:XRTXNews ReleaseXORTX Announces Rescheduling of Special Meeting of Shareholders
2023-10-12 07:00U:XRTXNews ReleaseXORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for ‚  the Share Consolidation Resolution
2023-10-04 07:00U:XRTXNews ReleaseXORTX Calls Special Meeting of Shareholders
2023-09-28 07:00U:XRTXNews ReleaseXORTX Sponsored Study Selected for Presentation at the American Society of Nephrology ¢ € “ Kidney Week 2023
2023-09-11 07:00U:XRTXNews ReleaseXORTX Announces Participation ‚  at Upcoming Investor Conferences
2023-09-07 07:00U:XRTXNews ReleaseXORTX Joins the Kidney Foundation and Kidney March
2023-08-29 07:00U:XRTXNews ReleaseXORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
2023-08-04 17:00U:XRTXNews ReleaseXORTX Appoints Chief Financial Officer
2023-06-29 08:00U:XRTXNews ReleaseXORTX Announces Results of ‚  Annual and Special Meeting of Shareholders
2023-06-23 20:51U:XRTXNews ReleaseXORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company ¢ € ™s Upcoming Annual and Special Meeting of Shareholders
2023-06-06 07:00U:XRTXNews ReleaseXORTX Announces PKD Presentation
2023-05-24 07:00U:XRTXNews ReleaseXORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
2023-05-04 07:00U:XRTXNews ReleaseFDA Confirms Eligibility of XORLO ¢ „ ¢ ‚  for Accelerated Approval